Search Results for 'Merck, Pfizer Form Diabetes Pact'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Merck, Pfizer Form Diabetes Pact

    April 29, 2013
    Will combine SGLT2 inhibitor with Januvia

  • Catalent, Cevec in Cell Line Sales Pact

    November 14, 2012
    Will jointly develop and market combined technologies

  • 04 Merck & Co., Inc.

    04 Merck & Co., Inc.

    Gil Roth || July 18, 2012
    #4 Merck & Co., Inc. One Merck Dr. P.O. Box 100 Whitehouse Station, NJ 08889-0100 Tel: (908) 423-1000 Fax: (908) 735-1253 www.merck.com Headcount                       …

  • 01 Pfizer

    01 Pfizer

    Gil Roth || July 14, 2011
    #1: Pfizer Headcount                         110,600 Year Established              2000 Pharma Revenues         …

  • GSK, Impax Enter Parkinson’s Pact

    December 16, 2010
    GlaxoSmithKline and Impax Pharmaceuticals entered an agreement for the development and commercialization of IPX066, Impax’s extended release carbidopa-levodopa product, outside the U.S. and Taiwan.

  • Pfizer To Shift R&D Focus

    September 30, 2008
    Pfizer will discontinue development of drugs for heart disease, obesity and bone health as part of its plan to focus research on Alzheimer's disease, diabetes, inflammation/immunology, oncology, pain and psychoses (schizophrenia), according to a comp…